IPO Analysis: Better Opportunities Await, Say Market ExpertsDefault Banner

IPO Analysis: Better Opportunities Await, Say Market Experts

Writer
TEAM
Status
Online
Timer

Suraksha Diagnostic, specializing in pathology and radiology testing services, derives most of its revenue from West Bengal. While the company faced a financial setback in FY23, it has recently shown signs of recovery, according to Swastika Investment.

  • Suraksha Diagnostic's Rs 846 crore IPO opens for subscription. Check GMP, other details - The Economic Times
  • Suraksha Diagnostic IPO Day 1: GMP, Price Band, Subscription, Key Dates, and Review - The Economic Times
  • Suraksha Diagnostic IPO opens today: Is it worth investing? Analysts weigh - Business Standard
  • Suraksha Diagnostic IPO opens today: Should you subscribe or avoid the issue? - Business Today
    • No items found.
    Follow us on social media:
    Thank you! Your submission has been received!
    Oops! Something went wrong while submitting the form.